STOCK TITAN

Jackson Financial Inc. 424B Filings

JXN NYSE

Every 424B that Jackson Financial Inc. (JXN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow JXN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JXN filings page.

Rhea-AI Summary

Jackson Financial Inc. is offering $750,000,000 aggregate principal amount of 6.150% senior notes due 2037. Interest accrues from June 15, 2026 and will be paid semi‑annually beginning on July 15, 2026. The notes are unsecured, rank equally with the Issuer’s other senior unsecured indebtedness and are structurally subordinated to liabilities of its subsidiaries. The Issuer expects net proceeds of approximately $741.9 million to be used for general corporate purposes and may include repayment or redemption of certain 2027 notes.

Rhea-AI Summary

Jackson Financial Inc. is offering senior unsecured notes under a preliminary prospectus supplement. The notes will be unsecured senior obligations that rank equally with the Issuer’s other unsecured senior indebtedness, bear interest payable semi‑annually and will be issued in book‑entry form through DTC.

The prospectus supplement states proceeds are expected to be used for general corporate purposes, which may include repaying or redeeming the Issuer’s $400,000,000 5.170% Senior Notes due 2027 and/or Jackson National Life’s $250,000,000 8.15% surplus notes due 2027. The offering is a new issue and there is currently no established public market for the notes.

Rhea-AI Summary

Jackson Financial Inc. registers up to 4,715,554 shares of common stock for resale by the selling securityholder.

This prospectus supplement states the Company will receive no proceeds from these sales and notes 70,385,737 shares outstanding as of the prospectus date. The shares were issued under an Investment Agreement and the selling securityholder is subject to transfer and lock-up restrictions, including an ownership ceiling of 9.9%, a two-year minimum hold period, and post‑closing selling limits described in the prospectus supplement.